55 related articles for article (PubMed ID: 16482213)
21. Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor.
Dijkers PF; van Dijk TB; de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
Oncogene; 1999 Jun; 18(22):3334-42. PubMed ID: 10362354
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic fusion tyrosine kinases as molecular targets for anti-cancer therapy.
Gunby RH; Sala E; Tartari CJ; Puttini M; Gambacorti-Passerini C; Mologni L
Anticancer Agents Med Chem; 2007 Nov; 7(6):594-611. PubMed ID: 18045055
[TBL] [Abstract][Full Text] [Related]
23. TEL-fusion oncogenic tyrosine kinases determine leukemic cells response to idarubicin.
Majsterek I; Slupianek A; Blasiak J
Anticancer Drugs; 2003 Sep; 14(8):625-31. PubMed ID: 14501384
[TBL] [Abstract][Full Text] [Related]
24. IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma.
Prokoph N; Probst NA; Lee LC; Monahan JM; Matthews JD; Liang HC; Bahnsen K; Montes-Mojarro IA; Karaca-Atabay E; Sharma GG; Malik V; Larose H; Forde SD; Ducray SP; Lobello C; Wang Q; Luan SL; Pospíšilová Š; Gambacorti-Passerini C; Burke GAA; Pervez S; Attarbaschi A; Janíková A; Pacquement H; Landman-Parker J; Lambilliotte A; Schleiermacher G; Klapper W; Jauch R; Woessmann W; Vassal G; Kenner L; Merkel O; Mologni L; Chiarle R; Brugières L; Geoerger B; Barbieri I; Turner SD
Blood; 2020 Oct; 136(14):1657-1669. PubMed ID: 32573700
[TBL] [Abstract][Full Text] [Related]
25. Interferon Independent Non-Canonical STAT Activation and Virus Induced Inflammation.
Nan Y; Wu C; Zhang YJ
Viruses; 2018 Apr; 10(4):. PubMed ID: 29662014
[TBL] [Abstract][Full Text] [Related]
26. The Philadelphia chromosome in leukemogenesis.
Kang ZJ; Liu YF; Xu LZ; Long ZJ; Huang D; Yang Y; Liu B; Feng JX; Pan YJ; Yan JS; Liu Q
Chin J Cancer; 2016 May; 35():48. PubMed ID: 27233483
[TBL] [Abstract][Full Text] [Related]
27. Anaplastic large cell lymphoma-propagating cells are detectable by side population analysis and possess an expression profile reflective of a primitive origin.
Moti N; Malcolm T; Hamoudi R; Mian S; Garland G; Hook CE; Burke GA; Wasik MA; Merkel O; Kenner L; Laurenti E; Dick JE; Turner SD
Oncogene; 2015 Apr; 34(14):1843-52. PubMed ID: 24814516
[TBL] [Abstract][Full Text] [Related]
28. STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.
Dorritie KA; McCubrey JA; Johnson DE
Leukemia; 2014 Feb; 28(2):248-57. PubMed ID: 23797472
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies.
Medves S; Demoulin JB
J Cell Mol Med; 2012 Feb; 16(2):237-48. PubMed ID: 21854543
[TBL] [Abstract][Full Text] [Related]
30. BCR/ABL stimulates WRN to promote survival and genomic instability.
Slupianek A; Poplawski T; Jozwiakowski SK; Cramer K; Pytel D; Stoczynska E; Nowicki MO; Blasiak J; Skorski T
Cancer Res; 2011 Feb; 71(3):842-51. PubMed ID: 21123451
[TBL] [Abstract][Full Text] [Related]
31. The lymphoma-associated fusion tyrosine kinase ITK-SYK requires pleckstrin homology domain-mediated membrane localization for activation and cellular transformation.
Rigby S; Huang Y; Streubel B; Chott A; Du MQ; Turner SD; Bacon CM
J Biol Chem; 2009 Sep; 284(39):26871-81. PubMed ID: 19535334
[TBL] [Abstract][Full Text] [Related]
32. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.
Santos SC; Lacronique V; Bouchaert I; Monni R; Bernard O; Gisselbrecht S; Gouilleux F
Oncogene; 2001 Apr; 20(17):2080-90. PubMed ID: 11360192
[TBL] [Abstract][Full Text] [Related]
33. Fusion tyrosine kinases: a result and cause of genomic instability.
Penserga ET; Skorski T
Oncogene; 2007 Jan; 26(1):11-20. PubMed ID: 16785987
[TBL] [Abstract][Full Text] [Related]
34. What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?
Turner SD; Alexander DR
Leukemia; 2005 Jul; 19(7):1128-34. PubMed ID: 15902287
[TBL] [Abstract][Full Text] [Related]
35. Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells.
Turner SD; Alexander DR
Leukemia; 2006 Apr; 20(4):572-82. PubMed ID: 16482213
[TBL] [Abstract][Full Text] [Related]
36. Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis.
Slupianek A; Hoser G; Majsterek I; Bronisz A; Malecki M; Blasiak J; Fishel R; Skorski T
Mol Cell Biol; 2002 Jun; 22(12):4189-201. PubMed ID: 12024032
[TBL] [Abstract][Full Text] [Related]
37. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
